deltatrials
Unknown OBSERVATIONAL NCT05969990

Tryptophan Metabolites in Pediatric Migraine

Exploration of the Role of Tryptophan Metabolites in Pediatric Migraine

Sponsor: Qilu Hospital of Shandong University

Conditions Migraine in Children
Interventions tryptophan metabolites in plasma
Updated 4 times since 2023 Last updated: Jul 23, 2023 Started: Jan 1, 2022 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05969990, this observational or N/A phase trial focuses on Migraine in Children and remains ongoing. Sponsored by Qilu Hospital of Shandong University, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotRecruiting~Feb 2025 – present · 17 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Feb 2025 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2024 — Feb 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Sep 2023 — Jul 2024 [monthly]

    Recruiting

    First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Qilu Hospital of Shandong University
Data source: Qilu Hospital of Shandong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations